LifeStance Health Group, Inc. (LFST) Hit a 52 Week High, Can the Run Continue?

LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Investment Research • Sep 3, 2026

LifeStance to Present at Upcoming Investor Conferences

SCOTTSDALE, Ariz., Sept. 01, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that management will present at the following upcoming investor conferences.

GlobeNewsWire • Sep 1, 2026

4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds

An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient and Home Healthcare industry. DVA, LFST, OPCH and AVAH stand to benefit.

Zacks Investment Research • Aug 28, 2026

Bet on These 5 Low-Leverage Stocks as Bond Yields Dip

Low-leverage stocks like NVIDIA and Valero Energy could offer investors resilience amid market volatility and uncertainty.

Zacks Investment Research • Aug 26, 2026

LifeStance Health Group (LFST) Is Up 3.44% in One Week: What You Should Know

Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research • Aug 13, 2026

5 Low-Leverage Stocks to Buy as High Oil Prices Shake Investor Confidence

High oil prices and market volatility spotlight five low-leverage stocks with strong earnings growth and resilient balance sheets.

Zacks Investment Research • Aug 12, 2026

LifeStance Survey Finds Women Want Mental Healthcare Built Into Perimenopause and Menopause Care

One in Three Women Don't Know Perimenopause Can Cause Anxiety, Depression and Mood Changes; Majority Who Seek Mental Healthcare Find It Helpful  SCOTTSDALE, Ariz., Aug. 11, 2026 /PRNewswire/ -- A LifeStance Health survey of 1,000 women experiencing perimenopause or menopause released today reveals this life stage carries an unexpected mental health toll, as one in three women (33%) report being unaware that perimenopause can cause mental health-related symptoms.

PRNewsWire • Aug 11, 2026

LifeStance Health Group, Inc. (LFST) Soars to 52-Week High, Time to Cash Out?

LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Investment Research • Aug 11, 2026

LifeStance Health (LFST) Upgraded to Buy: Here's Why

LifeStance Health (LFST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • Aug 11, 2026

LifeStance Health Group Q2 Earnings Call Highlights

LifeStance Health Group NASDAQ: LFST reported second-quarter results that exceeded its prior expectations, driven by higher visit volumes, increased revenue per visit and continued clinician productivity gains. The outpatient mental health provider raised its full-year revenue, Center Margin and adjusted EBITDA guidance.

MarketBeat • Aug 6, 2026